A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study.
BACKGROUND
Randomized trials have largely failed to support an effect of antioxidant vitamins on the risk of cardiovascular disease (CVD). Few trials have examined interactions among antioxidants, and, to our knowledge, no previous trial has examined the individual effect of ascorbic acid (vitamin C) on CVD.


METHODS
The Women's Antioxidant Cardiovascular Study tested the effects of ascorbic acid (500 mg/d), vitamin E (600 IU every other day), and beta carotene (50 mg every other day) on the combined outcome of myocardial infarction, stroke, coronary revascularization, or CVD death among 8171 female health professionals at increased risk in a 2 x 2 x 2 factorial design. Participants were 40 years or older with a history of CVD or 3 or more CVD risk factors and were followed up for a mean duration of 9.4 years, from 1995-1996 to 2005.


RESULTS
A total of 1450 women experienced 1 or more CVD outcomes. There was no overall effect of ascorbic acid (relative risk [RR], 1.02; 95% CI, 0.92-1.13 [P = .71]), vitamin E (RR, 0.94; 95% CI, 0.85-1.04 [P = .23]), or beta carotene (RR, 1.02; 95% CI, 0.92-1.13 [P = .71]) on the primary combined end point or on the individual secondary outcomes of myocardial infarction, stroke, coronary revascularization, or CVD death. A marginally significant reduction in the primary outcome with active vitamin E was observed among the prespecified subgroup of women with prior CVD (RR, 0.89; 95% CI, 0.79-1.00 [P = .04]; P value for interaction, .07). There were no significant interactions between agents for the primary end point, but those randomized to both active ascorbic acid and vitamin E experienced fewer strokes (P value for interaction, .03).


CONCLUSIONS
There were no overall effects of ascorbic acid, vitamin E, or beta carotene on cardiovascular events among women at high risk for CVD.
Cook
Nancy R
NR
Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, 900 Commonwealth Ave E, Boston, MA 02215, USA. ncook@rics.bwh.harvard.edu
Albert
Christine M
CM
Gaziano
J Michael
JM
Zaharris
Elaine
E
MacFadyen
Jean
J
Danielson
Eleanor
E
Buring
Julie E
JE
Manson
JoAnn E
JE
D000328:Adult; D000368:Aged; D000975:Antioxidants / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008875:Middle Aged; D014810:Vitamin E / Q000627:therapeutic use*; D014815:Vitamins / Q000627:therapeutic use*; D019207:beta Carotene / Q000627:therapeutic use*
D000975:Antioxidants; D014815:Vitamins; D019207:beta Carotene; D014810:Vitamin E; D001205:Ascorbic Acid
N Engl J Med. 1997 Aug 7;337(6):408-16
9241131
J Nutr. 2006 Oct;136(10):2588-93
16988131
Arch Intern Med. 2004 Nov 22;164(21):2335-42
15557412
N Engl J Med. 1993 May 20;328(20):1450-6
8479464
JAMA. 2007 Feb 28;297(8):842-57
17327526
JAMA. 1996 Mar 6;275(9):699-703
8594267
N Engl J Med. 1996 May 2;334(18):1150-5
8602180
Lancet. 1999 Aug 7;354(9177):447-55
10465168
JAMA. 2005 Mar 16;293(11):1338-47
15769967
N Engl J Med. 1994 Apr 14;330(15):1029-35
8127329
Nutr Rev. 2005 Aug;63(8):290-3
16190316
J Natl Cancer Inst. 1999 Dec 15;91(24):2102-6
10601381
J Natl Cancer Inst. 1993 Sep 15;85(18):1483-92
8360931
N Engl J Med. 1989 Apr 6;320(14):915-24
2648148
Am J Clin Nutr. 2005 Oct;82(4):879-86
16210720
Lancet. 2000 Oct 7;356(9237):1213-8
11072938
N Engl J Med. 1993 May 20;328(20):1444-9
8479463
N Engl J Med. 2000 Jan 20;342(3):154-60
10639540
Lancet. 1996 Mar 23;347(9004):781-6
8622332
Lancet. 1997 Jun 14;349(9067):1715-20
9193380
Lancet. 1994 Sep 10;344(8924):721-4
7915779
Am J Clin Nutr. 1996 Aug;64(2):190-6
8694019
JAMA. 2002 Nov 20;288(19):2432-40
12435256
Lancet. 2001 Jan 13;357(9250):89-95
11197445
Am J Epidemiol. 1998 Jan 15;147(2):180-6
9457009
J Womens Health (Larchmt). 2004 Jan-Feb;13(1):99-117
15006283
Circulation. 2003 Feb 25;107(7):947-53
12600905
Stroke. 2004 Jul;35(7):1584-8
15178820
N Engl J Med. 1996 May 2;334(18):1156-62
8602181
N Engl J Med. 2006 Feb 16;354(7):669-83
16481635
Circulation. 2003 Aug 19;108(7):802-7
12900344
JAMA. 2005 Jul 6;294(1):56-65
15998891
N Engl J Med. 1996 May 2;334(18):1145-9
8602179
N Engl J Med. 2001 Nov 29;345(22):1583-92
11757504
Ann Intern Med. 2005 Jan 4;142(1):37-46
15537682
Curr Opin Lipidol. 2005 Feb;16(1):47-54
15650563